Hand Sanitizer Recalled Due to Life-Threatening Bacteria

The FDA said concerns about Burkholderia cepacia contamination led DermaRite Industries to add several over-the-counter products including hand sanitizers, cleansers, skin protectants, and deodorant to last month's recall.
Published: 9/10/2025, 2:24:10 PM EDT
Hand Sanitizer Recalled Due to Life-Threatening Bacteria
Photo of one of the additional recalled DermaRite products. (Courtesy of FDA)

The U.S. Food and Drug Administration (FDA) announced that a popular skin and wound care company expanded its voluntary nationwide recall of hand soap to include two hand sanitizers and more than 14 additional products.

Concerns about Burkholderia cepacia contamination led DermaRite Industries to add several over-the-counter products, including hand sanitizers, cleansers, skin protectants, and deodorant, according to an FDA advisory.

The expanded recall includes no rinse wash cream 4-N-1, skin protectant DermaCerin, antifungal cream DermaFungal, skin protectant DermaMed, instant hand sanitizer GelRite, foaming hand sanitizer Hand E Foam, skin protectant Lantiseptic, skin protectant PeriGuard, skin protectant Renew Dimethicone, skin protectant Renew Periprotect, skin cream Renew Skin Repair, deodorant UltraSure, body wash Whirlbath Balance, skin and hair cleanser DermaVera.

The expiration date listed on the additional product packaging is August 2027.

The CDC defines Burkholderia cepacia complex as a group of bacteria commonly found in soil and water, and symptoms of contamination include serious respiratory infections, especially in patients with cystic fibrosis or other chronic lung disease, as well as fever and fatigue.

Last month, DermaRite recalled its antiseptic handwashing lotion soap made with Vitamin E called DermaKleen, topical analgesic cream DermaSarra, an antimicrobial foam soap made with aloe vera called KleenFoam, and an antiseptic cleanser used in the perineal area called PeriGiene.

“Burkholderia Cepacia Complex in these products may result in serious and life-threatening infections,” the company said in a press release. “In healthy individuals with minor skin lesions the use of the product will more likely result in local infections, whereas in immunocompromised individuals the infection is more likely to spread into blood stream leading to life-threatening sepsis.”

Company leaders did not respond to requests for comment about the expanded recall by the time of publication.

DermaRite’s Monica Johnson previously told NTD about last month's recall, “We are committed to the safety and satisfaction of our customers. Out of an abundance of caution, we issued a voluntary press release. FDA is aware of this recall and we are working with them.”

The recalled products were also distributed in Puerto Rico.

DermaRite is a manufacturer of skin and wound care products that are often used by health care facilities.

"DermaRite has notified its distributors and customers by e-mail to immediately examine available inventory and destroy all affected products in accordance with each facility’s process," the FDA said.

The FDA urged consumers to contact their physician or health care provider if they have experienced any problems that may be related to taking or using the withdrawn products.